Cadila Healthcare Q2 PAT up by 6% YoY to Rs 597 cr, revenue up 3%

The company's EBIDTA margin for the quarter was 22.7 per cent, up by 50 basis points

After adjusting for exceptional items and one-off gain on the account of sale of animal health established market undertaking, Cadila Healthcare Ltd's (Zydus Cadila)'s profit after tax (PAT) for quarter ended September 30, 2021 stood at Rs 597 crore, up 6 per cent on a year-on-year (YoY) basis.

For the second quarter ended September 30, 2021, Zydus Cadila posted a consolidated revenue of Rs 3,785 crore, up 3 per cent YoY, along with a six per cent growth in its earnings before interest, depreciation and tax (EBIDTA) for  Rs 861 crore. The company's EBIDTA margin for the quarter was 22.7